Volume 27, Number 4—April 2021
CME ACTIVITY - Research
Infections with Tickborne Pathogens after Tick Bite, Austria, 2015–2018
Table 2
Variable | Not infected, n = 457 |
Infected, n = 25 |
p value | |||
---|---|---|---|---|---|---|
No. or mean ± SD | Median, % (IQR) | No. or mean ± SD | Median, % (IQR) | |||
Sex | ||||||
M | 214 | 46.8 | 12 | 48.0 | 1.000 | |
F |
243 |
53.2 |
13 |
52.0 |
NA |
|
Age, y |
48.7 ± 14.5 |
48.5 (36.8–59.1) |
52.4 ± 14.0 |
54.0 (42.9–58.6) |
0.216 |
|
Use of repellent | 17 | 3.7 | 2 | 8.0 | 0.258 | |
No. ticks | 1.3 ± 1.2 | 1.0 (1.0–1.0) | 2.4 ± 3.8 | 1.0 (1.0–2.0) | <0.001 | |
Time, tick bite to blood test, d† | 4.3 ± 4.0 | 4.0 (2.0–6.0) | 3.9 ± 2.1 | 3.0 (2.0–5.0) | 0.645 | |
Duration of tick attachment, d |
1.0 ± 2.9 |
1.0 (0.0–2.0) |
1.2 ± 1.2 |
1.0 (0.0–2.0) |
0.668 |
|
Tick location | ||||||
Left leg | 119 | 26.0 | 15 | 60.0 | <0.001 | |
Right leg | 130 | 28.4 | 13 | 52.0 | 0.022 | |
Left arm | 53 | 11.6 | 6 | 24.0 | 0.106 | |
Right arm | 55 | 12.0 | 4 | 16.0 | 0.530 | |
Head/neck | 21 | 4.6 | 1 | 4.0 | 1.000 | |
Abdomen/chest | 71 | 15.5 | 4 | 16.0 | 1.000 | |
Genital/pelvic area | 111 | 24.3 | 5 | 20.0 | 0.811 | |
Back |
46 |
10.1 |
4 |
16.0 |
0.314 |
|
Antimicrobial drug‡ | 30 | 6.6 | 0 | 0.0 | 0.39 | |
PCR positive | 62 | 13.6 | 11 | 44.0 | <0.001 | |
IgG§ | 57 | 12.5 | 6 | 24.0 | 0.08 | |
IgM§ | 30 | 6.6 | 2 | 8.0 | 0.58 | |
IgG and IgM§ | 23 | 5.0 | 2 | 8.0 | 0.37 | |
History of erythema migrans |
84 |
18.0 |
8 |
32.0 |
0.15 |
|
Tick engorgement | ||||||
None | 180 | 39.5 | 4 | 16.0 | <0.001 | |
Slightly/partially | 219 | 48.0 | 10 | 40.0 | NA | |
Fully | 57 | 12.5 | 11 | 44.0 | NA |
*IQR, interquartile range; NA, not applicable. †Time between tick bite and first blood test. ‡Received within 4 weeks before tick bite. §Presence of Borrelia-specific antibodies at the first visit.
Page created: January 11, 2021
Page updated: March 18, 2021
Page reviewed: March 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.